Literature DB >> 3770062

Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration.

H Quiding, P Anderson, U Bondesson, L O Boréus, P A Hynning.   

Abstract

Plasma concentrations of codeine and its demethylated metabolite, morphine, were determined after single and repeated oral administration of codeine. Twelve healthy volunteers received two doses of codeine 60 mg, 2.8 h apart. In order to achieve steady-state conditions codeine 60 mg was then taken every 8 h for a further five doses. The plasma concentrations of codeine and morphine after the first, second and seventh doses were analyzed by GC-MS. The maximum plasma concentrations of codeine and morphine were reached about 1 h after administration and this time interval did not change on repeated administration. The peak plasma codeine was higher after the second dose of codeine than after the first and the concentration resembled that at steady-state. For morphine, the plasma concentration did not increase significantly after the second dose. Both after a single dose and during steady-state the plasma concentration of morphine was only 2-3% of that of codeine. It seems unlikely that morphine plays a significant role in the analgesic efficacy of single or repeated doses of codeine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3770062     DOI: 10.1007/bf00608214

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  MORPHINE AND NORMORPHINE IN THE BRAINS OF RATS GIVEN IDENTICALLY ANALGAESIC DOSES OF MORPHINE, CODEINE OR NORMORPHINE.

Authors:  T JOHANNESSON; J SCHOU
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  Analgesic potency of normorphine in patients with postoperative pain.

Authors:  L LASAGNA; T J DE KORNFELD
Journal:  J Pharmacol Exp Ther       Date:  1958-11       Impact factor: 4.030

3.  The effect of N-demethylation on certain pharmacologic actions of morphine, codeine, and meperidine in the mouse.

Authors:  J W MILLER; H H ANDERSON
Journal:  J Pharmacol Exp Ther       Date:  1954-10       Impact factor: 4.030

4.  [Not Available].

Authors:  G SANFILIPPO
Journal:  Boll Soc Ital Biol Sper       Date:  1948-06

5.  Analgesic effect of morphine glucuronides.

Authors:  K Shimomura; O Kamata; S Ueki; S Ida; K Oguri; H Yoshimura; H Tsukamoto
Journal:  Tohoku J Exp Med       Date:  1971-09       Impact factor: 1.848

6.  Analgesic efficacy after single and repeated doses of codeine and acetaminophen.

Authors:  H Quiding; V Oikarinen; J Sane; A M Sjöblad
Journal:  J Clin Pharmacol       Date:  1984-01       Impact factor: 3.126

7.  Gas-chromatographic measurement of codeine and norcodeine in human plasma.

Authors:  M K Brunson; J F Nash
Journal:  Clin Chem       Date:  1975-12       Impact factor: 8.327

8.  Codeine and propoxyphene in postepisiotomy pain. A two-dose evaluation.

Authors:  C M Gruber
Journal:  JAMA       Date:  1977-06-20       Impact factor: 56.272

9.  Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics.

Authors:  J W Findlay; E C Jones; R F Butz; R M Welch
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

10.  Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone.

Authors:  W T Beaver; S L Wallenstein; A Rogers; R W Houde
Journal:  J Pharmacol Exp Ther       Date:  1978-10       Impact factor: 4.030

View more
  16 in total

1.  Lack of effect of paracetamol on the pharmacokinetics and metabolism of codeine in man.

Authors:  A Somogyi; F Bochner; Z R Chen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Toxicogenetics--cytochrome P450 microarray analysis in forensic cases focusing on morphine/codeine and diazepam.

Authors:  H Andresen; C Augustin; T Streichert
Journal:  Int J Legal Med       Date:  2012-08-17       Impact factor: 2.686

3.  Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.

Authors:  Q Y Yue; J O Svensson; C Alm; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

4.  Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.

Authors:  Z R Chen; A A Somogyi; G Reynolds; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

5.  The postoperative pharmacokinetics of codeine.

Authors:  K Persson; M Hammarlund-Udenaes; O Mortimer; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  The effect of quinidine on the analgesic effect of codeine.

Authors:  S H Sindrup; L Arendt-Nielsen; K Brøsen; P Bjerring; H R Angelo; B Eriksen; L F Gram
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  Infants and young children metabolise codeine to morphine. A study after single and repeated rectal administration.

Authors:  H Quiding; G L Olsson; L O Boreus; U Bondesson
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

8.  Impact of environmental and genetic factors on codeine analgesia.

Authors:  J Desmeules; M P Gascon; P Dayer; M Magistris
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

9.  A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine.

Authors:  Q Y Yue; J O Svensson; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

10.  Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.

Authors:  Q Y Yue; J Hasselström; J O Svensson; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.